To evaluate the impact of the eosinophil-related chemokine CCL11 during STm infection, we administered a CCL11 neutralizing antibody or an isotype control antibody to mice three days post-infection, with subsequent doses every 3 days until sacrifice at 4 w.p.i.30 (Fig. 2a). The gene discussed is CCL11; the disease is infection.